EQ logo Equillium : EQ

EQ

Stock Data

$2.08

Change up

$0.04 (1.96%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory or immuno-inflammatory disorders with unmet medical needs. The company is headquartered in La Jolla, California.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.